The application of CHA2DS2-VASc score in ischemic stroke patients with non-valvular atrial fibrillation
	    		
		   		
		   			 
		   		
	    	
    	 
    	10.3936/j.issn.1002-0152.2014.01.005
   		
        
        	
        		- VernacularTitle:CHA2DS2-VASc评分在非瓣膜性房颤缺血性脑卒中患者中的应用
- Author:
	        		
		        		
		        		
			        		Pengfei GAO
			        		
			        		;
		        		
		        		
		        		
			        		Qinbao QIN
			        		
			        		
		        		
		        		
		        		
 
			        		
			        		
		        		 
- Publication Type:Journal Article
- Keywords:
        			
	        			
	        				
	        				
			        		
				        		CHA2DS2-VASc score;
			        		
			        		
			        		
				        		Non-valvular atrial fibrillation (NVAF);
			        		
			        		
			        		
				        		Ischemic stroke
			        		
			        		
	        			
        			
        		
- From:
	            		
	            			Chinese Journal of Nervous and Mental Diseases
	            		
	            		 2014;(1):21-25
	            	
            	
- CountryChina
- Language:Chinese
- 
		        	Abstract:
			       	
			       		
				        
				        	Objective To study the relationship between CHA2DS2-VASc score and intracranial atherosclerosis, Chinese ischemic stroke subclassification (CISS) classification and the early neurological outcomes in ischemic stroke pa-tients with non-valvular atrial fibrillation (NVAF), and to evaluate the clinical value of CHA2DS2-VASc score. Methods The retrospective analysis method was used. The data from 149 cases of ischemic stroke patients with NVAF was retro-spectively analyzed. The clinical data mainly included clinical manifestations, routine lab tests, imaging examinations such as the color-echo doppler, brain CT and/or MRI and angiographic studies of CTA and/or MRA of brain, CHA2DS2-VASc score, the CISS and the National Institutes of Health stroke scale (NIHSS). Results The CHA2DS2-VASc score was significantly higher in patients with intracranial atherosclerosis than those without [(5.13±1.39) vs. (4.14±1.67)] (P<0.05). The occurrence rates of intracranial atherosclerosis were significantly different among different CHA 2DS2-VASc score subgroups (0~1, 2~3, 4~5 and≥6 subgroups) (P<0.05). There were significant differences in CHA2DS2-VASc score among CS+LAA group, CS+LAA+PAD,group CS, group and CS+PAD group (all P<0.05). There was statistical difference in CHA2DS2-VASc score between patients with and without improvements (P<0.05). Conclusion The CHA2DS2-VASc score may be associated with concomitant intracranial atherosclerosis of ischemic stroke patients with NVAF which can be used to predict the condition of intracranial atherosclerosis. The CHA2DS2-VASc score is positively correlated with se-verity of ischemic stroke with NVAF which can be used to predict the disease improvements in patient with NVAF.